about us

our services

the library

contact us

PharmaCI

Prague Marriott Hotel
Prague, Czech Republic | 21-22 February 2017

|  VISIT HOST'S SITE  |

DO PLEASE POP BY THE INOVIS BOOTH FOR A VISIT!
INOVIS conference booth
experienced in their field

INOVIS PRESENTS ...

LATE LIFECYCLE MANAGEMENT – GX/BIOSIMILAR ISSUES, INTELLIGENCE OPTIONS, AND ACTIONS

MASTERCLASS / WORKSHOPS, 20 FEB 12:45 - 3:15
and CONFERENCE DAY ONE, 13 SEP 12:45 - 3:15

Planning for external and internal threats is a fundamental and essential part of brand planning.

This interactive workshop session will enable you to:

This workshop session (with breakouts), will give participants first-hand insights from combined +20 years of experience helping Big Pharma optimize their late-life cycle strategies – i.e. enabling companies to protect and optimize their assets. This interactive session will cover issues encountered (clinical, regulatory, commercial, IP, data exclusivity), the intelligence options (early encounters all the way to the endgame – what, where, why) and actions (which undertakings can be implemented – highlighting proven, successful and legal strategies)

Presenters

Dr. Baljit Singh, Managing Director and Partner, Lifesciences, INOVIS (formerly Director of Integrated Insights at Novartis)

View Baljit Singh (Ph.D.)'s profile on LinkedIn

Dr. Satish Kumar, Head, CI Strategies, Generics & Biosimilars, INOVIS

About ProACT

ProACT is a web-based strategic tool that enables systematic and objective scenario development and action planning

INOVIS ProACT Scenario Planning Tool
 | LEARN MORE |

INOVIS PRESENTS ...

IMPACTING STRATEGIES – RETHINKING THE ROLE OF COMPETITIVE INTELLIGENCE

CONFERENCE DAY ONE, 21 FEB 2:45 - 3:45

Moderator:
Baljit Singh, Ph.D., Managing Director and Partner, INOVIS, Pharmaceuticals and Life Sciences Division (formerly Director, Integrated Insights, Novartis)

This session takes a critical look at the following key questions:

Panel Discussion

The session will end with a panel discussion consisting of Big Pharma participants around “Where do we go from here?” and “What measures can we put in place to make the CI function/role more impactful to put intelligence into context and enable strategic decision making?” and “How can CI get a seat at the C-suite table and ensure the function’s viability, visibility, increased funding, and growth?”



_

© INOVIS Inc. All Rights Reserved
| web site map |

US | EAST COAST
PH 1.305.913.1350
info@inovis.global

US | WEST COAST
PH 1.650.298.8555
info@inovis.global

EUROPE | LUCERNE
PH 41.41.455.2522
info@inovis.global

site designed and maintained by tmwstudio